A Comparison of the Dexamethasone Implant (Ozurdex®) and Inferior Fornix-Based Sub-Tenon Triamcinolone Acetonide for Treatment of Inflammatory Ocular Diseases
Marie‐Hélène Errera(University of Pittsburgh), José‐Alain Sahel(University of Pittsburgh), P. Goldschmidt(Centre hospitalier national d'ophtalmologie des Quinze-Vingts), Raphaëlle Orès(McGill University), Sabrina Falah(Inserm), Jonathan Benesty(Inserm), Emmanuel Héron(Centre hospitalier national d'ophtalmologie des Quinze-Vingts), Jérôme Smadja(Inserm), Ana C. Pratas(Centre hospitalier national d'ophtalmologie des Quinze-Vingts), Bahram Bodaghi(Sorbonne Université), A. Bensemlali(Inserm), Mark Westcott(Barts Health NHS Trust), Neila Sédira(Centre hospitalier national d'ophtalmologie des Quinze-Vingts)
Cited by 11
Related Papers
2018 update of the EULAR recommendations for the management of Behçet's syndrome
|Annals of the Rheumatic Diseases|2018|771
EULAR recommendations for the management of Behçet disease
|Annals of the Rheumatic Diseases|2008|721
Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations
|Lara D. Veeken|2007|301
Inherited Retinal Degenerations: Current Landscape and Knowledge Gaps
|Translational Vision Science & Technology|2018|262
Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)
|Annals of the Rheumatic Diseases|2012|207